首页 | 本学科首页   官方微博 | 高级检索  
     

地塞米松影响结肠癌细胞对奥沙利铂与氟脲嘧啶化疗敏感性的实验研究*
引用本文:周进明,钟大平,周琪,彭秋平,潘凤,何颖,王雪,梁后杰. 地塞米松影响结肠癌细胞对奥沙利铂与氟脲嘧啶化疗敏感性的实验研究*[J]. 中国肿瘤临床, 2010, 37(3): 142-145. DOI: 10.3969/j.issn.1000-8179.2010.03.006
作者姓名:周进明  钟大平  周琪  彭秋平  潘凤  何颖  王雪  梁后杰
作者单位:第三军医大学西南医院肿瘤科(重庆市400038)① 解放军第521 医院肿瘤科
基金项目:本文课题受国家自然科学基金资助 
摘    要:目的:检测糖皮质激素受体在结肠癌组织及细胞株中的表达,探讨地塞米松共处理或预处理24h,结肠癌细胞株对奥沙利铂和氟脲嘧啶化疗敏感性的变化。方法:采用免疫组化检测糖皮质激素受体在61例结肠癌组织标本及4 种结肠癌细胞株中的表达;Hoechst33342 染色、流式细胞仪检测体外地塞米松对结肠癌细胞株的凋亡诱导作用;以MTT 法检测地塞米松共处理或预处理24h 后,结肠癌Lovo 细胞株对奥沙利铂和氟脲嘧啶化疗敏感性的变化。结果:在57.3% 的结肠癌组织标本中糖皮质激素受体呈阳性表达,在四种结肠癌细胞株中仅Lovo 和HCT-116表达糖皮质激素受体,HT- 29和SW- 480 细胞不表达。单独应用地塞米松后,对糖皮质激素受体阳性的Lovo 和HCT-116 细胞有较强的促凋亡作用,对不表达糖皮质激素受体的HT- 29和SW- 480 细胞作用则不明显。以1 ×10-4 mol/L的地塞米松处理Lovo 细胞24h,或与奥沙利铂共处理可使奥沙利铂的 IC 50从(13.7 ± 1.3)μ g/mL 降低至(5.9 ± 0.6)μ g/mL 和(4.8 ± 0.7)μ g/mL;同样处理可使氟脲嘧啶的IC 50从(72.2 ± 8.1)μ g/mL 降低至(21.1 ± 4.1)μ g/mL 和(18.6 ± 4.0)μ g/mL。结论:部分结肠癌组织及细胞株表达糖皮质激素受体。地塞米松体外作用能够促进糖皮质激素受体阳性的结肠癌细胞发生凋亡,与奥沙利铂和氟脲嘧啶预处理或共处理后可以增加结肠癌细胞的化疗敏感性。 

关 键 词:结肠癌   糖皮质激素受体   地塞米松   奥沙利铂   氟脲嘧啶
收稿时间:2009-05-21

The Effect of Dexamethasone on the Chemosensitivity of Colon Carcinoma Cells to L-OHP and 5-Fu Treatment
ZHOU Jinming,ZHONG Daping,ZHOU Qi,PENG Qiuping,PAN Feng,HE Ying,WANG Xue,LIANG Houjie. The Effect of Dexamethasone on the Chemosensitivity of Colon Carcinoma Cells to L-OHP and 5-Fu Treatment[J]. Chinese Journal of Clinical Oncology, 2010, 37(3): 142-145. DOI: 10.3969/j.issn.1000-8179.2010.03.006
Authors:ZHOU Jinming  ZHONG Daping  ZHOU Qi  PENG Qiuping  PAN Feng  HE Ying  WANG Xue  LIANG Houjie
Affiliation:1Department of Oncology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
Abstract:Objective: To examine the expression of glucocorticoid receptor in human colon cancinoma tis-sues and call lines and to explore the survival of colon cancer cell lines treated with dexamethasone alone or in combination with 5-Fu and L-OHP in a way of dexamethasone pretreatment or co-administration in vitro.Methods: The expression of glucocorticoid receptor was detected in 61 cases of colon cancer tissue samples and 4 types of colon cancer cell lines by immunohistochemistry. Apoptosis was detected by Hoechst33342 staining and flow cytometry. MTT assay was employed to detect the chemosensitivity of colon carcinoma cells to L-OHP and 5-Fu with dexamethasone pretreatment for 24 hours or co-administretion. Results: Positive GR expression was found in 57.3% colon cancer tissue samples and in Lovo and HCT-116 cell lines, not in HT-29 and SW-480. Apoptosis was detected in GR-expressed Lovo and HCT-116 cells at 72 hours after 1×10~(-4)mol/L Dex treatment, and the rates of apoptosis were higher than those in the control groups without Dex (P<0.01),GR-negative cells, HT-29 and SW-480 even treated with 1 × 10~(-4)mol/L Dex for 72 hours. Pretreatment and co-administration for Lovo cells with 1×10~(-4)mol/L Dex could decrease the IC50 of L-OHP from 13.7±1:1.3μg/mL to 5.9±0.6μg/mL and 4.8±0.7μg/mL, respectively. IC50 of 5-Fu was decreased from 72.2±8.1 μg/mL to 21.1±4.1μg/mL and 18.6±4.0μg/mL, respectively. Conclusion: There is expression of glucocorticoid receptor in part of colon carcinoma tissue samples and cell lines. Apoptosis does occur in GR-expressed Lovo and HCT-116 cells induced by dexamethasone in vitro. Pretreatment for 24h and co-administration with Dex can increase the chemosensitivity of Lovo cells to L-OHP and 5-Fu.
Keywords:Colon carcinoma  Glucocorticoid receptor  Dexamethasone  Oxaliplatin  5-fluorouracil
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号